Literature DB >> 8550446

Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis.

D van Soolingen1, P E de Haas, R M Blumenthal, K Kremer, M Sluijter, J E Pijnenburg, L M Schouls, J E Thole, M W Dessens-Kroon, J D van Embden, P W Hermans.   

Abstract

Restriction endonuclease PvuII plays a central role in restriction fragment length polymorphism analysis of Mycobacterium tuberculosis complex isolates with IS6110 as a genetic marker. We have investigated the basis for an apparent dichotomy in PvuII restriction fragment pattersn observed among strains of the M. tuberculosis complex. The chromosomal regions of two modified PvuII restriction sites, located upstream of the katG gene and downstream of an IS1081 insertion sequence, were studied in more detail. An identical 10-bp DNA sequence (CAGCTGGAGC) containing a PvuII site was found in both regions, and site-directed mutagenesis analysis revealed that this sequence was a target for modification. Strain-specific modification of PvuII sites was identified in DNA from over 80% of the nearly 800 isolates examined. Furthermore, the proportion of modifying and nonmodifying strains differs significantly from country to country.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550446      PMCID: PMC177623          DOI: 10.1128/jb.178.1.78-84.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  48 in total

1.  Sequence, internal homology and high-level expression of the gene for a DNA-(cytosine N4)-methyltransferase, M.Pvu II.

Authors:  T Tao; J Walter; K J Brennan; M M Cotterman; R M Blumenthal
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

2.  Characterization of the cloned BamHI restriction modification system: its nucleotide sequence, properties of the methylase, and expression in heterologous hosts.

Authors:  J E Brooks; P D Nathan; D Landry; L A Sznyter; P Waite-Rees; C L Ives; L S Moran; B E Slatko; J S Benner
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

3.  A family of regulatory genes associated with type II restriction-modification systems.

Authors:  T Tao; J C Bourne; R M Blumenthal
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

4.  Interaction of AluI, Cfr6I and PvuII restriction-modification enzymes with substrates containing either N4-methylcytosine or 5-methylcytosine.

Authors:  V Butkus; S Klimasauskas; L Petrauskiene; Z Maneliene; A Lebionka; A Janulaitis
Journal:  Biochim Biophys Acta       Date:  1987-08-25

5.  Isolation and restriction endonuclease analysis of mycobacterial DNA.

Authors:  R Patel; J T Kvach; P Mounts
Journal:  J Gen Microbiol       Date:  1986-02

6.  Gene pvuIIW: a possible modulator of PvuII endonuclease subunit association.

Authors:  G M Adams; R M Blumenthal
Journal:  Gene       Date:  1995-05-19       Impact factor: 3.688

7.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  Strain variation in the katG region of Mycobacterium tuberculosis.

Authors:  Y Zhang; D Young
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

9.  Cloning of a restriction-modification system from Proteus vulgaris and its use in analyzing a methylase-sensitive phenotype in Escherichia coli.

Authors:  R M Blumenthal; S A Gregory; J S Cooperider
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

10.  Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis.

Authors:  P W Hermans; D van Soolingen; J W Dale; A R Schuitema; R A McAdam; D Catty; J D van Embden
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

View more
  7 in total

1.  Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains.

Authors:  Kristin Kremer; Catherine Arnold; Angel Cataldi; M Cristina Gutiérrez; Walter H Haas; Stefan Panaiotov; Robin A Skuce; Philip Supply; Adri G M van der Zanden; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Genotypic characterization of five subspecies of Mycobacterium kansasii.

Authors:  M Picardeau; G Prod'Hom; L Raskine; M P LePennec; V Vincent
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease.

Authors:  R M Warren; G D van der Spuy; M Richardson; N Beyers; M W Borgdorff; M A Behr; P D van Helden
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.

Authors:  K Kremer; D van Soolingen; R Frothingham; W H Haas; P W Hermans; C Martín; P Palittapongarnpim; B B Plikaytis; L W Riley; M A Yakrus; J M Musser; J D van Embden
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  Molecular evidence for independent occurrence of IS6110 insertions at the same sites of the genome of Mycobacterium tuberculosis in different clinical isolates.

Authors:  Z Fang; D T Kenna; C Doig; D N Smittipat; P Palittapongarnpim; B Watt; K J Forbes
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis.

Authors:  R M Warren; G D van der Spuy; M Richardson; N Beyers; C Booysen; M A Behr; P D van Helden
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis.

Authors:  Scarlet S Shell; Erin G Prestwich; Seung-Hun Baek; Rupal R Shah; Christopher M Sassetti; Peter C Dedon; Sarah M Fortune
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.